Factors influencing time to diagnosis and initiation of treatment of endemic Burkitt Lymphoma among children in Uganda and western Kenya: A cross-sectional survey

Infectious Agents and Cancer

Volumn 8, Issue 1, 2013, Pages

  Buckle, Geoffrey C ^a   Collins, Jennifer Pfau ^b   Sumba, Peter Odada ^c   Nakalema, Beccy ^d   Omenah, Dorine ^c   Stiffler, Kristine ^e   Casper, Corey ^e   Otieno, Juliana A ^f   Orem, Jackson ^d   Moormann, Ann M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d UGANDA CANCER INSTITUTE   (Uganda)

^e USA   (United States)

^f Jaramogi Oginga Odinga Teaching and Referral Hospital   (Kenya)

Author keywords

Africa; Burkitt lymphoma; Cancer; Children; Delay; Delayed diagnosis; Kenya; Uganda

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; EYE DROPS;

ADULT; BURKITT LYMPHOMA; CROSS-SECTIONAL STUDY; DEMOGRAPHY; ENDEMIC DISEASE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HELP SEEKING BEHAVIOR; HOUSEHOLD; HUMAN; INCOME; KENYA; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PRIORITY JOURNAL; RESPONSIBILITY; REVIEW; SYMPTOM; TOOTH EXTRACTION; TRAFFIC AND TRANSPORT; UGANDA;

EID: 84884679089     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-8-36     Document Type: Review

References (33)

1. Spatial clustering of endemic Burkitt's lymphoma in high-risk regions of Kenya. Rainey JJ, Omenah D, Sumba PO, Moormann AM, Rochford R, Wilson ML, International journal of cancer Journal international du cancer 2007 120 1 121 127 Research Support, N.I.H., Extramural 10.1002/ijc.22179 17019706 (Pubitemid 44901926)
2. Cancer in Africa: epidemiology and prevalence. Burkitt Lymphoma. Parkin D, Hamdi-Cherif M, Sita F, et al. IARC Sci Publ 2003 153 324 328
3. Burkitt's lymphoma in Africa, a review of the epidemiology and etiology. Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E, Afr Health Sci 2007 7 3 166 175 Research Support, Non-U.S. Gov't Review 18052871
4. Diffuse large B-cell lymphomas and burkitt lymphoma. de Leval L, Hasserjian RP, Hematol Oncol Clin North Am 2009 23 4 791 827 Review 10.1016/j.hoc.2009.04.004 19577170
5. The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, et al. Blood 2001 97 11 3370 3379 Clinical Trial Research Support, Non-U.S. Gov't 10.1182/blood.V97.11.3370 11369626
6. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M, et al. Blood 1999 94 10 3294 3306 Clinical Trial Comparative Study Multicenter Study Research Support, Non-U.S. Gov't 10552938 (Pubitemid 29536122)
7. Burkitt's lymphoma. Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, et al. Lancet 2012 379 9822 1234 1244 Review 10.1016/S0140-6736(11) 61177-X 22333947
8. Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infection. Orem J, Maganda A, Mbidde EK, Weiderpass E, Pediatr Blood Cancer 2009 52 4 455 458 Research Support, Non-U.S. Gov't 10.1002/pbc.21769 18802952
9. CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma. Sandlund JT, Murphy SB, Santana VM, Behm F, Jones D, Berard CW, et al. J Clin Oncol 2000 18 16 3018 3024 Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S 10944136 (Pubitemid 30644127)
10. Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma. Hesseling PB, Molyneux E, Kamiza S, Broadhead R, Trans R Soc Trop Med Hyg 2008 102 6 602 607 Research Support, Non-U.S. Gov't 10.1016/j.trstmh.2008.02.009 18417177
11. Factors influencing time to diagnosis of childhood cancer in Ibadan, Nigeria. Brown BJ, Ajayi SO, Ogun OA, Oladokun RE, Afr Health Sci 2009 9 4 247 253 21503176
12. Late diagnosis of retinoblastoma in a developing country. Chantada G, Fandino A, Manzitti J, Urrutia L, Schvartzman E, Arch Dis Child 1999 80 2 171 174 10.1136/adc.80.2.171 10325735 (Pubitemid 29119732)
13. The experience in nicaragua: childhood leukemia in low income countries-the main cause of late diagnosis may be «medical delay» De Angelis C, Pacheco C, Lucchini G, Arguello M, Conter V, Flores A, et al. International journal of pediatrics 2012 2012 129707 22518173
14. Delay and causes of delay in the diagnosis of childhood cancer in Africa. Stefan DC, Siemonsma F, Pediatr Blood Cancer 2011 56 1 80 85 10.1002/pbc.22714 21108442
15. Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits. Brasme JF, Morfouace M, Grill J, Martinot A, Amalberti R, Bons-Letouzey C, et al. Lancet Oncol 2012 13 10 445 e459 Comparative Study Research Support, Non-U.S. Gov't Review 10.1016/S1470-2045(12)70361-3 23026830
16. Diagnosis delays in childhood cancer: a review. Dang-Tan T, Franco EL, Cancer 2007 110 4 703 713 Meta-Analysis Research Support, Non-U.S. Gov't Review 10.1002/cncr.22849 17620277 (Pubitemid 47257644)
17. Delayed diagnosis of leukemia and association with morbid-mortality in children in pernambuco, Brazil. Lins MM, Amorim M, Vilela P, Viana M, Ribeiro RC, Pedrosa A, et al. J Pediatr Hematol Oncol 2012 34 7 271 e276 10.1097/MPH.0b013e3182580bea 22935656
18. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. Fajardo-Gutierrez A, Sandoval-Mex AM, Mejia-Arangure JM, Rendon-Macias ME, Martinez-Garcia Mdel C, Med Pediatr Oncol 2002 39 1 25 31 Research Support, Non-U.S. Gov't 10.1002/mpo.10100 12116075 (Pubitemid 34556431)
19. Socioeconomic constraints to effective management of Burkitt's lymphoma in south-eastern Nigeria. Meremikwu MM, Ehiri JE, Nkanga DG, Udoh EE, Ikpatt OF, Alaje EO, Trop Med Int Health 2005 10 1 92 98 10.1111/j.1365-3156.2004.01348.x 15655018 (Pubitemid 40193690)
20. Community perceptions and factors influencing utilization of health services in Uganda. Bakeera SK, Wamala SP, Galea S, State A, Peterson S, Pariyo GW, Int J Equity Health. 2009 8 25 10.1186/1475-9276-8-25 19602244
21. Access to and utilisation of health services for the poor in Uganda: a systematic review of available evidence. Kiwanuka SN, Ekirapa EK, Peterson S, Okui O, Rahman MH, Peters D, et al. Trans R Soc Trop Med Hyg 2008 102 11 1067 1074 Research Support, Non-U.S. Gov't Review 10.1016/j.trstmh.2008.04.023 18565559
22. The kenya health system: analysis of the situation and enduring challenges. Wamai R, JAMJ 2009 52 2 134 140
23. Who is to blame? Perspectives of caregivers on barriers to accessing healthcare for the under-fives in Butere District, Western Kenya. Opwora AS, Laving AM, Nyabola LO, Olenja JM, BMC Public Health 2011 11 272 Comparative Study Research Support, Non-U.S. Gov't 10.1186/1471-2458-11-272 21539746
24. Cancer stigma and silence around the world: A LIVESTRONG report. LIVESTRONG 2010. Neal C, Beckjord E, Rechis R, Schaeffer J, Berno D, Duchover Y
25. Glanz K, Rimer BK, Theory at a glance. A guide for health promotion practice (2nd ed., NIH Pub. No. 97-3896) Washington, DC: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services 2005
26. Delayed diagnosis in retinoblastoma. Rodrigues KE, Latorre Mdo R, de Camargo B, J Pediatr (Rio J) 2004 80 6 511 516 Research Support, Non-U.S. Gov't (Pubitemid 44608519)
27. The problem of treatment abandonment in children from developing countries with cancer. Arora RS, Eden T, Pizer B, Pediatr Blood Cancer 2007 49 7 941 946 10.1002/pbc.21127 17252565 (Pubitemid 350022449)
28. The Guardians' perspective on paediatric cancer treatment in malawi and factors affecting adherence. Israels T, Chirambo C, Caron H, de Kraker J, Molyneux E, Reis R, Pediatr Blood Cancer 2008 51 639 642 10.1002/pbc.21703 18668516
29. Patient delay in cancer studies: a discussion of methods and measures. Andersen RS, Vedsted P, Olesen F, Bro F, Sondergaard J, BMC Health Serv Res 2009 9 189 Research Support, Non-U.S. Gov't 10.1186/1472-6963-9-189 19840368
30. Delay in diagnosis of children with cancer: a retrospective study of 315 children. Haimi M, Peretz Nahum M, Ben Arush MW, Pediatr Hematol Oncol 2004 21 37 48 14660305 (Pubitemid 38101409)
31. Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries. Pritchard-Jones K, Pieters R, Reaman GH, Hjorth L, Downie P, Calaminus G, et al. Lancet Oncol 2013 14 3 95 e103 Research Support, Non-U.S. Gov't 10.1016/S1470-2045(13)70010-X 23434338
32. Complex care systems in developing countries: breast cancer patient navigation in Ethiopia. Dye TD, Bogale S, Hobden C, Tilahun Y, Hechter V, Deressa T, et al. Cancer 2010 116 3 577 585 Research Support, Non-U.S. Gov't 10.1002/cncr.24776 20029968
33. Stata statistical software: release 11. StataCorp, Station TSLC College Station, TX: StataCorp LP 2009